ZELTIQ Aesthetics (ZLTQ): One Step Closer To Stable EPS Growth - Stifel
Get daily under-the-radar research with StreetInsider.com's Stealth Growth Insider Get your 2-Wk Free Trial here.
Stifel analyst, Jonathan Block, reiterated his Buy rating on shares of ZELTIQ Aesthetics (NASDAQ: ZLTQ) and raised the price target to $52 from $38. The analyst increased 2017 adjusted EBITDA margin 360 basis points (from 7.9% to 11.5%) while he expects the company to continue to spend on DTC and earmark more dollars internationally.
The combination of continued revenue growth (recurring revenue to total 70% of 2018 sales), margin expansion, and tax planning (Ireland manufacturing) sets the stage for ZELTIQ’s evolution into a sustainable EPS growth company with 2019 GAAP EPS of $1.53 (2019 cash EPS of $2.10).
Shares of ZELTIQ Aesthetics closed at $38.97 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Wedbush Raises Price Target on Citizens Financial Group (CFG) Following 3Q EPS Beat
- Netflix (NFLX) PT Raised to $140 at Guggenheim
- UPDATE: Stifel Starts Tabula Rasa Healthcare (TRHC) at Buy
Create E-mail Alert Related CategoriesAnalyst Comments, Analyst EPS Change, Analyst PT Change
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!